FT-003

N/A

Report date: 2025/03/14 14:27:16

Base Information

Drug NameFT-003
Drug Alias NameFT-003FT003
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV2 vector
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsDiabetic macular oedemaWet age-related macular degenerationMacular Degeneration +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesFrontera Therapeutics (Shanghai) Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesFrontera Therapeutics (Shanghai) Co LtdFangtuo Biotechnology (Suzhou) Co LtdFrontera Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedemaWet age-related macular degenerationMacular Degeneration +[4] 
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A